Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06953349 · ClinicalTrials.gov registry record
Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
A clinical trial of Open Angle Glaucoma, sponsored by Barnet Dulaney Perkins Eye Centers.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06953349 is a study of Open Angle Glaucoma that is actively recruiting participants, run by Barnet Dulaney Perkins Eye Centers. The registered enrollment target is 300 participants, roughly in line with the 324-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06953349, a study of Open Angle Glaucoma, is actively recruiting participants, sponsored by Barnet Dulaney Perkins Eye Centers.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Conditions Studied
Interventions
- PROCEDURE Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Study Locations (1)
Arizona
- Barnet Dulaney Perkins Eye Center - Mesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06953349
The ClinicalTrials.gov registry entry for NCT06953349 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 324-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target. The listed sponsor is Barnet Dulaney Perkins Eye Centers, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Angle Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis is the first listed.
NCT06953349 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06953349 about?
NCT06953349 is a clinical study titled "Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis". Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
What is the current status of trial NCT06953349?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-03-31. Estimated completion is 2025-12-31.
What conditions does trial NCT06953349 study?
This clinical trial studies the following conditions: Open Angle Glaucoma.
What interventions are being tested in trial NCT06953349?
The interventions under investigation include: Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis (PROCEDURE).
Who is sponsoring clinical trial NCT06953349?
This trial is sponsored by Barnet Dulaney Perkins Eye Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06953349 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
-
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.